Evidence map›Paper›PMID 34690929›Full record

ArticleFrontiers in endocrinology2021

Type 2 Diabetes Modifies Skeletal Muscle Gene Expression Response to Gastric Bypass Surgery.

Matthew D Barberio, G Lynis Dohm, Walter J Pories, Natalie A Gadaleta, Joseph A Houmard, Evan P Nadler, Monica J Hubal

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Matthew D BarberioCenter for Genetic Medicine Research, Children's National Research Institute, Washington, DC, United States.
G Lynis DohmDepartment of Physiology, Brody School of Medicine, East Carolina University, Greenville, NC, United States.
Walter J PoriesDepartment of Surgery, Brody School of Medicine, East Carolina University, Greenville, NC, United States.
Natalie A GadaletaDepartment of Exercise and Nutrition Sciences, Milken Institute School of Public Health, George Washington University, Washington, DC, United States.
Joseph A HoumardHuman Performance Laboratory, Department of Kinesiology, College of Health and Human Performance, East Carolina University, Greenville, NC, United States.
Evan P NadlerDivision of Pediatric Surgery, Children's National Hospital, Washington, DC, United States.
Monica J HubalCenter for Genetic Medicine Research, Children's National Research Institute, Washington, DC, United States.
East Carolina University · USMilken Institute · USChildren's National · USIndiana University – Purdue University Indianapolis · US

Funding

Clinical and Translational Science Institute at Children's NationalUL1TR000075 · NCATS · CHILDREN'S RESEARCH INSTITUTE · PI GUAY-WOODFORD, LISA MARIE · 2012 to 2015
$13.7M
NCATS NIH HHS UL1 TR000075
6 · The paper itself

Abstract

Introduction: Roux-en-Y gastric bypass (RYGB) is an effective treatment for type 2 diabetes mellitus (T2DM) that can result in remission of clinical symptoms, yet mechanisms for improved skeletal muscle health are poorly understood. We sought to define the impact of existing T2DM on RYGB-induced muscle transcriptome changes. Methods: Vastus lateralis biopsy transcriptomes were generated pre- and 1-year post-RYGB in black adult females with (T2D; Results: Pre-RYGB, 95 probes were downregulated with T2D including subunits of mitochondrial complex I. Post-RYGB, the T2D group had normalized gene expression when compared to their non-diabetic counterparts with only three probes remaining significantly different. In the T2D, we identified 52 probes upregulated from pre- to post-RYGB, including NDFUB7 and NDFUA1. Conclusion: Black females with T2DM show extensive downregulation of genes across aerobic metabolism pathways prior to RYGB, which resolves 1 year post-RYGB and is related to improvements in clinical markers. These data support efficacy of RYGB for improving skeletal muscle health, especially in patients with T2DM.

Indexed as

Gastric BypassTranscriptomeAdultBiopsyCase-Control StudiesDiabetes Mellitus, Type 2FemaleGene ExpressionGene Expression ProfilingHumansMiddle AgedMuscle, SkeletalObesityTreatment OutcomeUnited Statesbariatric (weight-loss) surgerygene expressionmetabolismskeletal muscletype 2 diabetes (T2D)

Identifiers

PMID34690929
PMCPMC8526857
OpenAlexW3202211267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.